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Abstract
The Radiotherapy treatment planning optimization process based on a quasi-Newton algorithm with
an object function containing dose-volume constraints is not guaranteed to converge when the dose
value in the dose-volume constraint is a critical value of the dose distribution. This is caused by finite
differentiability of the dose-volume histogram at such values. A closer look near such values reveals
that convergence is most likely not at stake, but it might be slowed down.
1 Introduction
A recent development in Radiotherapy treatment planning is to use an optimization process to obtain a
treatment plan. To do so one needs to formalize the clinical objectives in a so called object function whose
optimum should correspond to an optimal treatment plan. Many current treatment planning systems rely
on a quasi-Newton algorithm to perform the optimization. In order to guarantee that this process indeed
converges to an optimum the object function should at least be twice continuously differentiable. This
last property is the main subject of this study. As it turns out the object functions used in Radiotherapy
do not always have this property so that convergence of the optimization process can not directly be
guaranteed in those cases.
In section 2 we present some background for the use of optimization in Radiotherapy treatment planning.
The object functions currently used are built from so called dose-volume and EUD constraints. By dose-
volume constraints, the dose-volume histogram enters the object function. It is the finite differentiability
of the former that causes the insufficient differentiability of the latter. In section 3 this relationship is
explained in more detail. A example illustrates how finite differentiability of the object function influences
the optimization process. The practical consequences thereof are the subject of section 4. Where section
3 is kept informal, section 5 provides formal statements and proofs of the differentiability results. This
last section does not contain new arguments but serves as a support for the exposition.
2 Background for optimization in Radiotherapy
2.1 Optimization in Radiotherapy
In Radiotherapy treatment planning a careful choice of values for treatment parameters is necessary to
obtain a dose distribution in the patient that meets criteria for eradicating a malignant tumour. At the
same time it should meet criteria so that healthy tissues and organs are not critically damaged. Due
to the fact that dose is deposited in every irradiated part of the patient, these criteria are conflicting in
almost every clinical situation. Experienced planners are usually very good at intuitively balancing such
conflicting goals, still there is a need for more objective and quantifiable methods to devise and evaluate
treatment plans. This has led to the construction of object functions, depending on treatment parameters,
which formalize the objectives of dose on tumours and healthy tissues, see [1, 8, 9]. By optimizing this
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object function with respect to treatment parameters, one hopes to get an optimal treatment plan.
Another, very different, reason to use optimization in treatment planning is the emergence of IMRT
where the sheer number of treatment parameters simply precludes manual planning.
Even if we know that a function has a unique optimum, there is no simple recipe to find it. Therefore
we have to resort to numerical, iterative methods to solve optimization problems, which, given a starting
point, generate a sequence converging to an optimum. The latter can be guaranteed only if certain
conditions on the object function are met. It seems, however, that if these conditions are considered at
all, it is taken for granted that they are fulfilled.
Many treatment planning systems use a quasi-Newton method, like the LBFGS algorithm, to find an
optimum of the object function, see for example [2] or [7] as a general reference. One of the conditions
guaranteeing that this algorithm yields a sequence locally converging to an optimum is that the object
function is twice continuously differentiable. The object functions currently used in treatment planning
systems are limited to so called EUD constraints and dose-volume constraints, or combinations of both,
see for example [8], but also see section 2.2 remark 1. Our results show that the former do satisfy
the differentiability condition. The latter however, do not, that is not for all values of the treatment
parameters.
2.2 Object functions in Radiotherapy
The goal of Radiotherapy treatment planning is to devise a treatment plan achieving a high tumour
control probability (TCP) combined with a low normal tissue complication probability (NTCP). A priori
both TCP and NTCP are unrelated to treatment parameters. Even relating them to criteria on the
dose distribution in the patient is a non-trivial task. To simplify matters one does not consider the 3-
dimensional dose distribution, but a derived quantity namely the dose-volume histogram for each relevant
region. The latter are tumours and healthy organs for which the dose-volume histogram tells which part
of the volume receives at least a certain dose, see equation (1) below. Data from previously treated
patients are used to relate TCP and NTCP to dose-volume histograms, see [3]. At this point further
simplifications are necessary, because TCP and NTCP can only be related to certain points of dose-
volume histograms or even only to averages. Generally for tumours this leads to dose-volume constraints,
that is a minimum and a maximum dose for volumes vmin and vmax respectively, or in a more concise
notation (dmin, vmin) and (dmax, vmax). In case of healthy tissues the situation is much more complicated,
in practice one uses a mixture of dose-volume constraints and EUD constraints, see [8].
Criteria for the dose distribution or the derived dose-volume histograms are related to treatment param-
eters, thus the treatment planning objectives can be expressed with an object function of these treatment
parameters. Now the object function used in treatment planning is a weighted sum of ’local’ object func-
tions, one for each dose-volume constraint or EUD constraint. Let us consider a tumour with a minimum
and a maximum dose-volume constraint. Furthermore Vσ is the dose-volume histogram of the tumour
for a given dose distribution and treatment parameters σ, that is Vσ(h) is the (relative) volume of the
tumour, region R, receiving at least dose h
Vσ(h) = vol{x ∈ R | fσ(x) ≥ h}. (1)
In this expression vol(A) is the volume of the region A and fσ is the dose distribution. One constructs
what we will call local object functions. For example the local object function for a minimum does-volume
constraint for a specific volume is a function Fmin(σ) which increases the more the actual relative volume
at dmin is below vmin and decreases or even becomes zero if the actual relative volume at dmin is above
vmin. Similarly a maximum dose object function Fmax(σ) is constructed such that it increases when the
relative volume at dmax is above vmax and decreases or becomes zero otherwise. Thus the object function
for the tumour alone would be the weighted sum of two local object functions, usually of the following
form
F (σ) = w1 Fmin(σ) + w2 Fmax(σ) = w1G(vmin − Vσ(dmin)) + w2G(Vσ(dmax)− vmax), (2)
where w1 > 0 and w2 > 0 are weights and
G(x) =
{
0, x < 0
x2, x ≥ 0,
(3)
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Although the object function F is a function of the treatment parameters σ it does not depend on them
directly, but only via the dose-volume histograms. The latter depend on the dose distribution which
directly depends on the treatment parameters.
The EUD constraints are in a similar way expressed in the equivalent uniform dose. A quantity used to
measure the biological effect of radiation especially for healthy tissues, see [6]. We denote the equivalent
uniform dose by Eα, here it is a function of treatment parameters σ
Eα(σ) =
[
1
vol(R)
∫
R
fσ(x)
α dx
]1/α
. (4)
Remarks
1. The word constraint in this context is somewhat misleading because a dose-volume nor an EUD
constraint is used as a constraint in the sense of constrained optimization. If they were, many if
not most optimization problems in treatment planning would have no solution. It is a common
clinical situation that a tumour is located adjacent to a critical organ. For several reasons the
region, called PTV, on which the treatment dose is prescribed is larger than the tumour. See [5] for
a systematic description of XTV’s, where X = G, C, I or P. Therefore the critical organ is possibly
partly located in the PTV. Suppose for example that one third of the volume of the critical organ
is located inside the PTV. Furthermore suppose that the minimal dose-volume constraint on the
PTV is 60 Gy (Gy is unit of dose) and the maximum average dose constraint on the organ is 20 Gy.
Since the dose distribution varies continuously in space and its gradient is bounded, this constrained
optimization problem will have no solution. Due to the anatomy a minimum dose of 60 Gy on the
PTV implies an average dose well above 20 Gy on the organ and vice versa. A weighted sum of
local object functions is a way to find a clinically acceptable compromise for this situation. To
avoid the term constraint some authors use the term soft constraint, but in my opinion this term is
superfluous because we already have the notion of object function. Nevertheless we adhere to the
word constraint, in order to stay in line with the existing literature.
2. The equivalent uniform dose, as defined in equation (4), can be regarded as a generalized average,
in fact for α = 1 it is the standard average of the dose distribution over the region R. Formally it
is identical to the Lp-norm of the dose distribution fσ restricted to a region R of the patient. But
p is called α and it has a biological interpretation. One associates a value of α to each tissue type,
but there is no agreement yet in the literature about these values.
3. The dose-volume histogram refers to the graph of a function that is usually given the same name.
This function, defined for each σ in equation (1), can be regarded as a volume function in the
sense of [4]. Let us fix σ for the moment. The dose-volume histogram of a region R is a function
h 7→ Vσ(h) whose value is the volume of R receiving at least dose h. In other words it gives the
volume of a region enclosed by two level sets of the dose distribution fσ, namely those x ∈ R where
fσ(x) = h and the x ∈ R where fσ(x) = maxR(fσ) (this last level set will be a point).
4. Any quantity that influences the dose distribution may be considered as a treatment parameter.
Usually treatment parameters are beam intensities and beam angles, that is parameters of the
treatment unit.
5. The object function F (σ) in equation (2) also depends on dmin, dmax, vmin, vmax, w1 and w2. Such
parameters might be called planning parameters. Here we will keep them fixed.
3 Differentiability of object functions in Radiotherapy
The numerical optimization process based on a quasi-Newton method converges locally to an optimum
if the object function is at least twice continuously differentiable. In the sequel we will simply say
differentiable. In current Radiotherapy practice the object function is a function of treatment parameters,
but only indirectly via dose-volume constraints and or EUD constraints. Here we will consider their
differentiability properties.
4 Convergence..., Hoveijn..., 29/nov/2008
Let us start with object functions only containing EUD constraints. Then F (σ) is a weighted sum of
local object functions involving only
G(dmin − Eα(σ)) and G(Eα(σ)− dmax)
like in equations (2) and (3). In this case the object function F is differentiable. Here we have to assume
that the dose distribution is differentiable.
However, when the object function contains dose-volume constraints it is not always differentiable. This is
due to the finite differentiability of the dose-volume histogram at critical values of the dose distribution,
even when the latter is differentiable. Since it is not immediately obvious how the differentiability of
the dose-volume histogram as a function of dose affects the differentiability of the object function as
a function of treatment parameters, we present the following explanation. Essentially, the treatment
parameters enter the argument of the volume function because in the presence of parameters, the critical
values are parameter dependent.
When treatment parameters vary, the dose distribution fσ varies and in particular its critical values.
Thus a critical value may pass through h. Suppose xσ = 0 is a critical point for σ = σ0 (a critical point
can always be translated to 0). It can be shown, see section 5, that for values of σ near σ0 and x near
0, fσ can be transformed to a new function fˆσ(x) = g(x) + fσ(xσ). Where g is a σ independent local
standard of fσ with critical point at zero and critical value zero and fσ(xσ) is the critical value of fˆσ for
σ near σ0.
Using the previous we will show in section 5 that Vσ(h) = Vglob(σ, h)+Vloc(σ, h) can be split into a global
and a local part. The global part depends differentiably on σ. Let us consider the local part in more
detail. On a neighbourhood O ⊂ R3 of 0 we have
Vloc(σ, h) ∝ vol{x ∈ O | fˆσ(x) ≥ h}
= vol{x ∈ O | g(x) + fσ(xσ) ≥ h}
= vol{x ∈ O | g(x) ≥ h− fσ(xσ)}
= Vg(h− fσ(xσ)).
The function Vloc(σ, h) is proportional to the volume in the expression above and the proportionality
factor is a differentiable function of σ. The last line in the formula above shows the volume function
Vg for a region enclosed by level sets of g. According to [4] this function is not twice continuously
differentiable at critical values of g. Thus Vloc(σ, h) is not twice continuously differentiable at values of σ
for which
h = fσ(xσ). (5)
This, in turn, means that the object function F is not twice continuously differentiable at values of σ
such that h is a critical value of fσ.
Remarks
1. The function G in equation (3) is not differentiable at 0. This alone would already imply that the
object function in (2) is not differentiable. However we will assume that we are in a situation like
in remark 1 where we are looking for a compromise. This means we stay away from points where
G is not differentiable.
2. Note that equation (5) defines a hyper surface Λ in parameter space Rm. It will bem−1-dimensional
in most of its points, therefore we need to vary only one parameter to pass through Λ.
3. Throughout we assume that the dose distribution is a differentiable function. If it were less differ-
entiable, the volume function would also be less differentiable for both critical and regular values.
3.1 Examples
The aim of this section is to provide two examples. One shows a differentiable object function, the
other shows an object function that fails to be twice continuously differentiable at a certain value of
the treatment parameters, here we take σ = 0. In the first case the Newton iteration converges to
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an optimum, wheras in the second case the Newton iteration does not converge if one of the iterates
becomes 0. To avoid lengthy calculations obscuring the points we wish to illustrate we will make several
simplifications.
d+
d+
dc dc
dmax dmax
x x
Figure 1: On the left the graph of fσ1(x, 0, 0) and on the right the graph of fσ2(x, 0, 0). d+, dmax and dc
are explained in the text.
Let fσ be a dose distribution on the region R. The object function consists of a single maximum dose-
volume constraint (dmax, vmax) so F (σ) = G(Vσ(dmax), vmax). The difference between the to examples will
be the dose distribution. Suppose for σ in a sufficiently large neighbourhood of σ1 the dose distribution
is a function with a single maximum and for a similar neighbourhood of σ2 it is a function with two
maxima for example:
fσ1(x, y, z) =
1
1 + x2 + y2 + z2
and fσ2(x, y, z) =
1
1 + x2 + y2 + z2
+
1
2 + (x− 4)2 + y2 + z2
.
Here σ1 and σ2 are different parameter values. In figure 1 we draw the functions fσ1(x, 0, 0) and
fσ2(x, 0, 0). For both dose distributions we call d+ the value at the global maximum and dc is the
value of the other local maximum of fσ2 . Both d+ and dc depend on the treatment parameters σ. Let
us assume that always dc < dmax < d+. Furthermore we assume that Vσ(dmax) < Vσ(dc).
For σ near σ1 the dose distribution has only one critical value namely d+ so for d < d+, Vσ(d) is
a differentiable function of σ which we call U . In the second case, where σ is near σ2, we will be
particularly interested in d = dc. For d near dc but d 6= dc, Vσ(d) is again a differentiable function. At
d = dc, Vσ(d) = U(σ) + Vg(dc − d) can be split in a local and a global part, as in the previous section,
where the global part is differentiable. We assume for simplicity that the global part is again U . The
local part Vg is essentially a function of the following form
Vg(h) =
{
αh
3
2 , h > 0
0, h ≤ 0,
where g is a local standard form of the dose distribution, α is a constant. Since the volume function Vg is
not differentiable at 0, the object function (that we will construct shortlye hereafter) is not differentiable at
values of σ for which d = dc. The latter defines a hyper surface Λ in parameter space of codimension one,
which means that we need to vary only one parameter to cross Λ. Therefore we choose new parameters
and the first one we take to be d − dc. Only this parameter will be relevant for the example, we call
it again σ, but now σ ∈ R. Thus for the second dose distribution we finally have the following volume
function:
Vσ(d) =
{
U(σ) + α(−σ)
3
2 , σ < 0
U(σ), σ ≥ 0.
(6)
Now we construct the object function. First we scale such that vmax = 1. Then the object function for
the first dose distribution is
F1(σ) = (U(σ)− 1)
2.
The object function for the second dose distribution is given by almost the same formula, but U is
replaced by the volume function in equation (6). The function U must satisfy several conditions so that
it is consistent with the dose distributions we chose. First U must be differentiable and decreasing,
furthermore U(0) > 1 since we assumed that Vσ(dmax) < Vσ(dc). A possible choice is U(σ) =
15
10+σ .
In the first optimization problem the object function F1 is differentiable so there are no difficulties in
applying the Newton algortihm. However, in the second optimization problem the object function F2 is
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not twice continuously differentiable at σ = 0. Recall that the 1-dimensional Newton iteration for F is
σn+1 = φ(σn) = σn−
F ′(σn)
F ′′(σn)
. Fixed points σ0 of φ correspond to extremal points of F if F
′′ is continuous
and nonzero at σ0. Since the limit from the left of the second derivative of F2 is unbounded, the Newton
iteration has a fixed point at σ = 0 which is not related to an minimum or maximum of F2. But this
’spurious’ fixed point is not stable for the Newton iteration φ. Only if σn = 0 the next iterates will also
be zero. Therefore it does not lead to convergence to a non extremal point of F in general. Although it
may slow down the convergence of the Newton iterates. For a graphical explanation see figure 2.
σ
σ
σn σn+1
Figure 2: In the left figure, the graph of F2 is indicated by a dashed line, F
′
2 by a solid line and F
′′
2 by
dotted line. The figure on the right shows a magnification of the graph of F ′2 near σ = 0. The dashed
lines indicate how the Newton iterate σn+1 is constructed from σn.
4 Conclusion
Our results show that the Radiotherapy treatment planning optimization process based on a quasi-
Newton method locally converges to an optimum of the object function for most values of the treatment
parameters. Only when the object function contains a dose-volume constraint (h, v), convergence can not
be guaranteed. The reason is that the object function is not sufficiently differentiable for values of the
treatment parameters such that h is a critical value of the dose distribution fσ. Although for all other
values of σ, the object function is differentiable. The question remains whether this leads to practical
consequences for optimization in treatment planning.
Let us take a closer look at the values of the treatment parameters for which the object function is not
sufficiently differentiable. In parameter space these values of σ are determined by the equation h = fσ(xσ),
see section 3, expressing that h is a critical value of the dose distribution. Geometrically this equation
defines a hyper surface Λ in parameter space. Roughly speaking Λ is m−1-dimensional so it has measure
zero. This means that given a starting point for optimization, the Newton iteration scheme generates a
sequence of points that will lie on Λ with probability zero. The points on Λ are spurious fixed points of
the Newton iteration like in the example of the previous section. The reason is that we can generalize this
example. First all types of extreme points of the dose distribution, namely minima, saddles and maxima
lead to the same type of non-differentiability of the volume function. Second, also in higher dimensions
the second derivative of the object function becomes unbounded at points of insufficient differentiability.
Third, the spurious fixed points of the Newton iteration scheme are unstable. Our final conclusion is that
in practice the convergence of the optimization process is most likely only slowed down near Λ.
5 Proof of differentiability statements
In order to make a statement about the differentiability of the object function, we need a few definitions.
Let Σ ⊂ Rm be an open set of m treatment parameters. Let D be a domain in R3 representing the
patient and let R ⊂ D represent a tumour region or a healthy organ. For each σ ∈ Σ, the dose
distribution is represented by a function fσ : D → R (here we do not consider fσ as a distribution in
the sense of generalized functions). A function is called smooth if it is infinitely many times continuously
differentiable. We now assume that fσ is a smooth function of position x ∈ D and moreover smoothly
dependent on the parameters σ ∈ Σ. Critical points of fσ are points in D where the gradient of fσ
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vanishes, other points are called regular points. The value fσ takes at a critical point is called a critical
value. If the level set {x ∈ R | fσ(x) = h} contains no critical points, h is called a regular value. We now
state our results on the differentiability of object functions containing EUD constraints and dose-volume
constraints respectively.
Theorem 1 Let the object function F : Σ → R be given by F (σ) = G(Eα(σ), h), where G : R × R → R
is a smooth function and Eα(σ) is the equivalent uniform dose. Then F is smooth with respect to σ.
Theorem 2 Let the object function F : Σ→ R be given by F (σ) = G(Vσ(h), v), where G : R×R→ R is
a smooth function and Vσ is a volume function for dose distribution fσ. Then F is smooth with respect
to σ provided that h is not a critical value of fσ. If h is a critical value of fσ0 , then F is not twice
continuously differentiable at σ = σ0.
The proof of theorem 1 is rather straightforward, but the proof of theorem 2 is more involved. Since
in the setting of theorem 2 the differentiability of the object function F is completely determined by
the volume function, the proof is about the latter only. The theorem contains two statements which we
here state and prove separately. The proofs heavily rely on the results in [4], but due to the presence of
parameters we have to make several adjustments. Let us start with some definitions.
Definitions
1. Let fσ : R
n → R be a positive smooth function for all σ ∈ Rm and moreover fσ depends smoothly
on σ. For each σ ∈ Σ, fσ vanishes at infinity in the following sense, for each ε > 0 there is a
compact K ⊂ Rn such that for all x ∈ Rn \K, fσ(x) < ε. We assume that critical points of fσ are
non-degenerate, that is if x is a critical point of fσ then det(Hess fσ(x)) 6= 0.
2. Also f : Rn × Rm → R is a smooth function with non-degenerate critical points. Although we
consider f and fσ as different functions, their values are taken to be identical: f(x, σ) = fσ(x) for
all x ∈ Rn and σ ∈ Rm.
3. We denote the level sets of fσ by Nh,σ = {x ∈ Rn | fσ(x) = h}.
4. The level sets of f are denoted by Nh = {(x, σ) ∈ R
n × Rm | f(x, σ) = h}.
Remark. Note that critical points of f are also critical points of fσ, but the opposite is not necessarily
true.
Proof of theorem 1. The function fσ is a positive and smooth function, smoothly depending on
parameters σ. Then [fσ]
α for α > 0 is also smooth in both variables an parameters. Now it immediately
follows that Eα(σ) as defined in equation (4) is again a smooth function of σ. 
The following two propositions essentially cover theorem 2.
Proposition 3 Let fσ and f be as defined above. Then Vσ(h) = voln{x ∈ Rn | fσ(x) ≥ h} depends
smoothly on σ at σ = σ0 if h is a regular value of fσ0 .
Proposition 4 Let fσ and Vσ(h) be as in the previous proposition. Then Vσ(h) is finitely differentiable
with respect to σ at σ = σ0 if h is a critical value of of fσ0 .
Let us begin with the nice situation where h is a regular value of fσ0 , so that Vσ(h) smoothly depends
on σ. In the proof of proposition 3 we use a property of the level sets Nh,σ of fσ.
Lemma 5 Let fσ and f be as defined above and furthermore h be a regular value of fσ0 . Then an
open neighbourhood Σ of σ0 exists, such that Nh,σ is diffeomorphic to Nh,σ0 for all σ ∈ Σ and the
diffeomorphism depends smoothly on σ.
Proof of proposition 3. The volume Vσ(h) is given by an integral over a region bounded by Nh,σ.
Since, according to lemma 5, the latter depends smoothly on σ at σ = σ0, the integral and thus Vσ(h)
depends smoothly on σ at σ = σ0. 
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It remains to prove lemma 5.
Proof of lemma 5. Let {σ = σ0} be a shorthand for {(x, σ) ∈ Rn × Rm | σ = σ0}. Note that
Nh,σ0 = {σ = σ0} ∩ Nh. Since h is a regular value, Nh,σ0 contains no critical points of fσ0 . Thus the
intersection of {σ = σ0} and Nh is transversal. Then a neighbourhood Σ of σ0 exists such that for all
σ1 ∈ Σ, the intersection of {σ = σ1} and Nh is transversal. Thus for all σ1 ∈ Σ, Nh,σ1 is a regular level
set, consequently there are no critical points of f in Nh,Σ = {(x, σ) ∈ Rn × Rm | x ∈ Nh,σ, σ ∈ Σ}.
Suppose σ1 ∈ Σ and σ1 6= σ0 then an index i exists such that σ1,i 6= σ0,i. Now the gradient flow of the
height function σi on Nh is a regular flow on Nh,Σ thus defining a diffeomorphism Φ from Nh,σ0 to Nh,σ1 .

Let us now turn to the case where h is a critical value of fσ0 . Then there is at least one critical point
xσ0 in Nh,σ0 , but for the sake of simplicity we assume that xσ0 is unique. In the proof of proposition 4
we will use a similar construction as in [4] without providing all details.
Proof of proposition 4. Let us assume that xσ0 is the unique critical point of fσ0 on the critical level
set Nh,σ0 . Since by assumption xσ0 is a non-degenerate critical point we can apply the implicit function
theorem to conclude that an open neighbourhood Σ of σ0 exists such that the map Σ → Rn : σ 7→ xσ
and xσ is a critical point of fσ is smooth. Now we define a new function gσ(x) = fσ(xσ + x), which is
a smooth function of x and σ ∈ Σ. Moreover gσ has a critical point at x = 0 with critical value fσ(xσ).
Then we have Vσ(h) = voln{x ∈ Rn | gσ(x) ≥ h}. Following the construction in [4] we split the latter
region in a part not containing the point 0 and a remaining small part including 0. The volume of the
first part depends smoothly on σ using the same arguments proving proposition 3. Since Vσ(h) is the
sum of both volumes, the differentiability of Vσ(h) is determined by that of the volume of the second
part.
Let us consider this second part contained in a small neighbourhood O of 0. We may assume that O is
small enough to put gσ into the standard form of [4]. In order to keep notation simple we denote the
standard form again by gσ, but now we can write gσ(x) = g(x) + fσ(xσ). The actual standard form is
g(x) =
∑p
i=1 x
2
i −
∑q
i=1 x
2
p+i, with p+ q = n. Note that g no longer depends on σ, it has a critical point
at x = 0 and the critical value is 0. This form can be obtained by a smooth change of coordinates, even
smoothly depending on σ. Here again we need the non-degeneracy of critical point of fσ. In the following
we use the results of [4]. As a function of k, the volume function Vloc(k) = voln{x ∈ O ⊂ Rn | g(x) ≥ k}
is only finitely differentiable with respect to k at k = 0.
Now the volume of the second part is proportional to Vloc(h − fσ(xσ)) = vol{x ∈ O ⊂ Rn | g(x) ≥
h − fσ(xσ)}. The proportionality factor is of no concern because it originates from smooth coordinate
changes and depends smoothly on σ. Thus we obtain that the differentiability of Vσ(h) with respect to
σ is determined by that of Vloc(h− fσ(xσ)). The latter is only finitely differentiable with respect to σ at
those values of σ where h− fσ(xσ) = 0. Or, put differently, where h is a critical value of fσ. 
Remarks
1. The statements and proofs in this section are valid for any dimension. Therefore we have not
specialized them to the case n = 3. In this respect finitely differentiable means less than two times
continuously differentiable.
2. The critical points of a parameter family of functions will generally be degenerate for certain
parameter values. However we excluded this possibility because the volume function will be even
less differentiable at a critical value when the critical point on the level set of this value is degenerate.
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